Company / Assets per Share
ARS Pharmaceuticals, Inc. Assets per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Assets per Share
$3.34
FY2025
5-year range
$2.13 / $9.27
FY2021-FY2025
Trend
-8.2%
vs FY2024
Sector context
#168 of 210
Health Care
What the data says
ARS Pharmaceuticals, Inc.'s assets per share of $3.34 is lower than 80% of companies in the Health Care sector (FY2025). Assets per Share has fluctuated over the past 6 years, ranging from $2.13 in FY2021 to $135.79 in FY2020.
Based on SEC 10-K filings.
3.34 in FY2025 with a 5-year CAGR of -52.3%.
Improved from $2.48 to $3.34 over the past 2 years.
Health Care sector context is included.
Assets per Share over time
Growth rates
- 3-Year CAGR
- -28.8%
- 5-Year CAGR
- -52.3%
- 10-Year CAGR
- -
Sector benchmark
Bottom 20% in Health CareTop 80% of 210This company $3.34 Sector average $353.15
▼
-99.1% below sector average
Key checks
Key Insights
- In FY2025, assets per share decreased 8.2% year-over-year.
- Ranks #168 out of 210 companies in the Health Care sector.
- Peak assets per share was recorded in FY2020.
- Lowest assets per share in the period was in FY2021.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
- Altman Z-Score -1.44 (distress zone, below 1.8 threshold)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Assets per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.34 | -8.2% |
| FY2024 | $3.64 | +46.7% |
| FY2023 | $2.48 | -73.2% |
| FY2022 | $9.27 | +335.4% |
| FY2021 | $2.13 | -98.4% |
| FY2020 | $135.79 | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026